Cathie's Ark Logo
undefined Logo

ARKK Holdings of Verve Therapeutics (VERV) - Updated Daily

Gene TherapyGenomicsCRSPR Gene Editing
Maxinomics Icon
Manufacturing is Coming Back to the US 🏗️
Date
Direction
Shares
Fund Weight
Fund
February 13, 2024
BUY29.618k0.0042%ARKK
February 8, 2024
BUY11.666k0.0017%ARKK
October 27, 2023
BUY72.653k0.011%ARKK
October 23, 2023
BUY206.560k0.0304%ARKK
July 7, 2023
BUY33.567k0.008%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0.55%$1.16b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
31🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
33$28.17
🎫ARK Ownership Percent
3.8%

Other ETFs That Hold VERV

Ticker
NameWeight
ARKGARK Genomic Revolution ETF2.46%
GNOMGlobal X Genomics & Biotechnology ETF1.1%
XBISPDR® S&P Biotech ETF0.82%
ARKKARK Innovation ETF0.36%
LABUS&P Biotech Bull 3X Shares ETF0.124%
IBBiShares Biotechnology ETF0.07%

Research Notes and Commentary for VERV

No Research Notes Found for VERV